Previous reports have suggested that in NSCLC cell lines, LKB1 mutations often occur concurrently with KRAS or BRAF mutations (Sanchez-Cespedes et al, 2002; Carretero et al, 2004). Here, KRAS is linked to non-small cell lung carcinoma.